Researchers at Northwestern University used a smartphone app to follow patients with neurological symptoms stemming from long ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

As detailed in a recently released paper, the SleepFM AI model analyzes a comprehensive suite of physiological recordings to ...

Mental health professionals told News18 that prolonged exposure to toxic air is increasingly linked to anxiety, low mood, ...

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

Approved as Quviviq in Japan, daridorexant is being marketed through a partnership between Nxera and Shionogi.

Can sleep affect the progression of Alzheimer’s disease? That’s what a study led by the University of Bristol will explore, thanks to a £4.3 million grant by the Medical Research Council (MRC).

University of Texas at Dallas researchers, in partnership with Texas-based biotech company EnLiSense, have demonstrated a ...

EMPOWER-ED was a two-arm, individually randomized trial with a 6-month follow-up conducted at Veterans Health Administration ...

Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ®Phase 3 trial of ...

Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...

Many seniors with dementia are being put at risk by brain-altering medications linked to falls, confusion and hospitalization ...